Insider Shareholders with Direct Ownership of Intra Cellular Therapies, Inc. (ITCI)
This section provides a comprehensive overview of the insiders with direct ownership of Intra Cellular Therapies, Inc. (ITCI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Intra-Cellular Therapies, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sharon Mates
Chairman and CEO |
1,289,112 | 2,502,504 | 1,135,235 $150 Million | 79 |
Mar 10, 2025
Reduced 0.88%
|
|
Christopher D Alafi
Director |
1,572 | 0 | 346,795 $45.7 Million | 3 |
Mar 31, 2021
Added 0.13%
|
| 73,289 | 137,945 | 48,238 $6.36 Million | 12 |
Feb 24, 2025
Added 12.69%
|
|
| 75,605 | 135,974 | 0 $0 | 25 |
Apr 02, 2025
Reduced 100.0%
|
|
| 83,773 | 91,340 | 0 $0 | 26 |
Apr 02, 2025
Reduced 100.0%
|
|
|
Lawrence J. Hineline
SVP of Finance, CFO |
566,678 | 574,712 | 0 $0 | 40 |
Mar 11, 2024
Reduced 100.0%
|
| 1,567 | 1,567 | 0 $0 | 2 |
Apr 02, 2025
Reduced 100.0%
|
|
|
Mark Neumann
EVP, Chief Commercial Officer |
409,670 | 431,134 | 0 $0 | 49 |
Apr 02, 2025
Reduced 100.0%
|
|
Suresh K. Durgam
EVP, Chief Medical Officer |
217,166 | 225,925 | 0 $0 | 40 |
Apr 02, 2025
Reduced 100.0%
|
|
Michael Halstead
President |
656,142 | 660,567 | 0 $0 | 51 |
Apr 02, 2025
Reduced 100.0%
|